Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery India 2013

Kenneth Gollob's Biography



Kenneth Gollob, Professor, Institute for Education and Research

Ken Gollob holds his bachelors in Molecular Biology from the University of Colorado, Boulder, and his Ph.D. in Immunology and Microbiology from CU Health Sciences Center and National Jewish Center, Denver. His post-doctorate was at DNAX Research Institute with Dr. Robert Coffman in Palo Alto, CA. He held Visiting Professor positions at the CDC and Stanford University School of Medicine. Currently, he is a Research Professor at the Hospital Santa Casa, IEP in Belo Horizonte, Brazil, and a PI with the Brazilian National Tropical Disease Institute (INCT-DT). He studies protective and pathogenic immune responses designed for the eventual development of novel therapies, diagnostics and biomarkers in leishmaniasis, Chagas disease and Dengue.

Kenneth Gollob Image

Challenges in Drug Development for Dengue Fever: Immunoregulatory Aspects Associated with Hemorrhagic Manifestations

Saturday, 28 September 2013 at 09:50

Add to Calendar ▼2013-09-28 09:50:002013-09-28 10:50:00Europe/LondonChallenges in Drug Development for Dengue Fever: Immunoregulatory Aspects Associated with Hemorrhagic ManifestationsDrug Discovery India 2013 in Banglore, IndiaBanglore, IndiaSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2013-09-27 00:00:002013-09-28 00:00:00Europe/LondonDrug Discovery India 2013Drug Discovery India 2013 in Banglore, IndiaBanglore, IndiaSELECTBIOenquiries@selectbiosciences.com